In vitro virulence characteristics of rare serovars of Salmonella enterica isolated from sand lizards (Lacerta agilis L.)

Antonie van Leeuwenhoek
Joanna MokrackaAnna Ekner-Grzyb

Abstract

The aim of this study was to estimate virulence potential of Salmonella enterica strains colonizing the gut of free-living sand lizards (Lacerta agilis L.). The strains belonged to three Salmonella serovars: Abony, Schleissheim, and Telhashomer. Adhesion and invasion abilities of the strains were determined in quantitative assays using the gentamicin protection method. Induction of apoptosis was assessed using HeLa cell monolayers. PCR assays were used for detection of 26 virulence genes localised within mobile elements: pathogenicity islands, virulence plasmids, and prophage sequences. In vitro studies revealed that all strains had adhesion and invasion abilities to human epithelial cells. The isolates were cytotoxic and induced apoptosis of the cells. The serovars differed in the number of virulence-associated genes: up to 18 genes were present in Salmonella Schleissheim, 17 in Salmonella Abony, whereas as few as six genes were found in Salmonella Telhashomer. Generally, Salmonella Abony and Salmonella Schleissheim did not differ much in gene content connected with the presence SPI-1 to -5. All of the strains lacked genes localised within bacteriophages and plasmids. The presence of virulence-associated genes and in vitro pat...Continue Reading

References

Feb 1, 1992·Epidemiology and Infection·M L Hall, B Rowe
Nov 14, 1997·Journal of Clinical Microbiology·D L WoodwardW M Johnson
Apr 1, 2000·Microbes and Infection·S L MarcusB B Finlay
Dec 16, 2000·Epidemiology and Infection·S UzzauJ E Olsen
Feb 24, 2001·International Journal of Medical Microbiology : IJMM·R PragerH Tschäpe
Dec 4, 2001·Veterinary Microbiology·L Geue, U Löschner
Jun 5, 2003·Emerging Infectious Diseases·Jorge HernandezBjörn Olsen
Apr 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Erik Haghjoo, Jorge E Galán
Jul 15, 2004·Environmental Microbiology·Víctor BrionesJosé F Fernández-Garayzábal
May 12, 2005·BMC Biotechnology·Deborah RibbleYiqun G Shellman
Sep 13, 2005·Veterinary Microbiology·Frank PasmansFreddy Haesebrouck
Apr 19, 2006·Avian Diseases·Jerod A SkybergLisa K Nolan
Dec 26, 2006·Journal of Bacteriology·Erin C BoyleB Brett Finlay
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Anne RytkönenDavid W Holden
Mar 6, 2010·Trends in Biochemical Sciences·Travis BeddoeJames C Paton
May 11, 2010·Microbial Pathogenesis·Sylwia KrzymińskaAdam Kaznowski
Dec 21, 2010·BMC Complementary and Alternative Medicine·Robert NawrotAnna Gozdzicka-Jozefiak
Feb 18, 2011·Veterinary Research·Karin HoelzerMartin Wiedmann
Jul 23, 2014·Research in Microbiology·Sylvie Issenhuth-JeanjeanFrançois-Xavier Weill
Oct 23, 2014·Nucleic Acids Research·Sung Ho YoonJihyun F Kim
Feb 11, 2015·TheScientificWorldJournal·A Andino, I Hanning
Jul 7, 2018·Journal of Veterinary Research·Magdalena SkarżyńskaDariusz Wasyl

❮ Previous
Next ❯

Citations

Jul 30, 2021·Veterinary Record Open·Barbara R VoglerSarah Albini

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

International Journal of Medical Microbiology : IJMM
M Hensel
Journal of Infection in Developing Countries
Miryan Margot Sánchez-JiménezS Rubino
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Ying-hui LiYa-qun Qiu
© 2022 Meta ULC. All rights reserved